Publication at First Faculty of Medicine |
2016
Abstract
This article presents case reports of two patients with type 2 diabetes in whom the use of linagliptin led to long-term excellent glycemic control, and offered the patients to maintain an active lifestyle without the risk of hypoglycaemia or drug interactions.